HealthDay News — Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study...
A new study by researchers from Arizona State University and their colleagues highlights a dietary strategy for significant health improvement and weight management. Participants following an...